25 XP   0   0   10

Knight Therapeutics Inc
Buy, Hold or Sell?

Let's analyse Knight Therapeutics Inc together

PenkeI guess you are interested in Knight Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Knight Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Knight Therapeutics Inc

I send you an email if I find something interesting about Knight Therapeutics Inc.

Quick analysis of Knight Therapeutics Inc (30 sec.)










What can you expect buying and holding a share of Knight Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€7.38
Expected worth in 1 year
€7.40
How sure are you?
66.7%

+ What do you gain per year?

Total Gains per Share
€0.02
Return On Investment
0.6%

For what price can you sell your share?

Current Price per Share
€3.94
Expected price per share
€3.88 - €4.2
How sure are you?
50%

1. Valuation of Knight Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)

€3.94

Intrinsic Value Per Share

€3.10 - €3.84

Total Value Per Share

€10.49 - €11.23

2. Growth of Knight Therapeutics Inc (5 min.)




Is Knight Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$793.2m$886.7m-$40.3m-4.8%

How much money is Knight Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$3m-$5.4m$2.3m77.6%
Net Profit Margin-5.9%-10.6%--

How much money comes from the company's main activities?

3. Financial Health of Knight Therapeutics Inc (5 min.)




What can you expect buying and holding a share of Knight Therapeutics Inc? (5 min.)

Welcome investor! Knight Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Knight Therapeutics Inc.

What can you expect buying and holding a share of Knight Therapeutics Inc?

First you should know what it really means to hold a share of Knight Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Knight Therapeutics Inc is €3.94. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Knight Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Knight Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €7.38. Based on the TTM, the Book Value Change Per Share is €0.01 per quarter. Based on the YOY, the Book Value Change Per Share is €0.05 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Knight Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.17-4.4%-0.02-0.5%-0.02-0.5%0.010.1%0.010.1%
Usd Book Value Change Per Share-0.45-11.4%0.010.1%0.061.4%0.4411.1%0.4411.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.45-11.4%0.010.1%0.061.4%0.4411.1%0.4411.1%
Usd Price Per Share3.74-3.44-4.04-4.02-4.02-
Price to Earnings Ratio-5.37-35.89-60.74-12.75-12.75-
Price-to-Total Gains Ratio-8.30-19.21--24.42-28.63-28.63-
Price to Book Ratio0.48-0.43-0.52-0.53-0.53-
Price-to-Total Gains Ratio-8.30-19.21--24.42-28.63-28.63-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.184674
Number of shares238
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.44
Usd Total Gains Per Share0.010.44
Gains per Quarter (238 shares)1.40103.67
Gains per Year (238 shares)5.59414.69
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
106-40415405
201120829820
30178012441235
402214016591650
502820020732065
603426024882480
703932029032895
804538033183310
905044037323725
1005650041474140

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%8.04.00.066.7%11.07.00.061.1%11.07.00.061.1%11.07.00.061.1%
Book Value Change Per Share3.01.00.075.0%8.04.00.066.7%12.06.00.066.7%12.06.00.066.7%12.06.00.066.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.018.00.0%0.00.018.00.0%0.00.018.00.0%
Total Gains per Share3.01.00.075.0%8.04.00.066.7%12.06.00.066.7%12.06.00.066.7%12.06.00.066.7%

Fundamentals of Knight Therapeutics Inc

About Knight Therapeutics Inc

Knight Therapeutics Inc. develops, manufactures, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices worldwide. It offers Tafasitamab for relapsed or refractory diffuse large B-cell lymphoma; Pemigatinib for metastatic cholangiocarcinoma; Akynzeo for prevention of chemotherapy-induced acute and delayed nausea and vomiting; Aloxi for prevention of acute nausea and vomiting associated with emetogenic cancer chemotherapy; Fostamatinib for chronic immune thrombocytopenia; Nerlynx for extended adjuvant breast cancer and metastatic breast cancer; Trelstar for advanced prostate cancer; Vidaza for myelodysplastic syndrome; Abraxane for metastatic pancreatic cancer; Halaven for metastatic breast cancer and soft tissue sarcoma; and Lenvima for advanced renal cell cancer and for differentiated thyroid cancer and unresectable hepatocellular carcinoma. The company provides Ladecvina for multiple myeloma and myelodysplastic syndrome, mantle cell lymphoma, and follicular lymphoma; Zyvalix for metastatic prostate cancer; Karfib for relapsed or refractory multiple myeloma; Leprid for advanced prostate cancer; Rembre for chronic myeloid leukemia; Palbocil for breast cancer; Ambisome and Cresemba for fungal infection; Impavido for leishmaniasis; Dolufevir for HIV infection; Exelon for dementia; and Ibsrela for irritable bowel syndrome with constipation. In addition, it offers Salofalk for ulcerative colitis; Ursofalk for biliary cirrhosis; Imvexxy for moderate to severe dyspareunia; Bijuva for vasomotor symptoms; Fibridoner for idiopathic pulmonary fibrosis; Toliscrin DPI for pseudomonas aeruginosa lung infection; Toliscrin 1-2 for severe acute or resistant chronic infections; and Tobradosa Haler for chronic lung infections. Further, it finances other life science companies; and invests in life sciences venture capital funds. The company was incorporated in 2013 and is headquartered in Montreal, Canada.

Fundamental data was last updated by Penke on 2024-04-05 05:43:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Knight Therapeutics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Knight Therapeutics Inc earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Knight Therapeutics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -32.8% means that €-0.33 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Knight Therapeutics Inc:

  • The MRQ is -32.8%. The company is making a huge loss. -2
  • The TTM is -5.9%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-32.8%TTM-5.9%-26.9%
TTM-5.9%YOY-10.6%+4.7%
TTM-5.9%5Y-2.7%-3.3%
5Y-2.7%10Y-2.7%0.0%
1.1.2. Return on Assets

Shows how efficient Knight Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Knight Therapeutics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -1.8% Return on Assets means that Knight Therapeutics Inc generated €-0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Knight Therapeutics Inc:

  • The MRQ is -1.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.8%TTM-0.3%-1.4%
TTM-0.3%YOY-0.5%+0.2%
TTM-0.3%5Y0.0%-0.3%
5Y0.0%10Y0.0%0.0%
1.1.3. Return on Equity

Shows how efficient Knight Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Knight Therapeutics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -2.2% Return on Equity means Knight Therapeutics Inc generated €-0.02 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Knight Therapeutics Inc:

  • The MRQ is -2.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -0.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.2%TTM-0.4%-1.8%
TTM-0.4%YOY-0.6%+0.2%
TTM-0.4%5Y0.0%-0.4%
5Y0.0%10Y0.0%0.0%

1.2. Operating Efficiency of Knight Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Knight Therapeutics Inc is operating .

  • Measures how much profit Knight Therapeutics Inc makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Knight Therapeutics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Knight Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.3%-0.3%
TTM0.3%YOY-5.6%+5.8%
TTM0.3%5Y-3.6%+3.9%
5Y-3.6%10Y-3.6%0.0%
1.2.2. Operating Ratio

Measures how efficient Knight Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.54 means that the operating costs are €1.54 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Knight Therapeutics Inc:

  • The MRQ is 1.540. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.515. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.540TTM1.515+0.025
TTM1.515YOY1.584-0.070
TTM1.5155Y1.635-0.120
5Y1.63510Y1.6350.000

1.3. Liquidity of Knight Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Knight Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.20 means the company has €3.20 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Knight Therapeutics Inc:

  • The MRQ is 3.202. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.206. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.202TTM3.206-0.004
TTM3.206YOY2.632+0.574
TTM3.2065Y3.481-0.275
5Y3.48110Y3.4810.000
1.3.2. Quick Ratio

Measures if Knight Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Knight Therapeutics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.76 means the company can pay off €1.76 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Knight Therapeutics Inc:

  • The MRQ is 1.755. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.836. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.755TTM1.836-0.080
TTM1.836YOY1.292+0.543
TTM1.8365Y1.745+0.090
5Y1.74510Y1.7450.000

1.4. Solvency of Knight Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Knight Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Knight Therapeutics Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.21 means that Knight Therapeutics Inc assets are financed with 21.0% credit (debt) and the remaining percentage (100% - 21.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Knight Therapeutics Inc:

  • The MRQ is 0.210. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.206. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.210TTM0.206+0.004
TTM0.206YOY0.182+0.024
TTM0.2065Y0.190+0.016
5Y0.19010Y0.1900.000
1.4.2. Debt to Equity Ratio

Measures if Knight Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Knight Therapeutics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 26.6% means that company has €0.27 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Knight Therapeutics Inc:

  • The MRQ is 0.266. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.260. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.266TTM0.260+0.006
TTM0.260YOY0.224+0.036
TTM0.2605Y0.249+0.010
5Y0.24910Y0.2490.000

2. Market Valuation of Knight Therapeutics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Knight Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Knight Therapeutics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -5.37 means the investor is paying €-5.37 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Knight Therapeutics Inc:

  • The EOD is -6.016. Based on the earnings, the company is expensive. -2
  • The MRQ is -5.374. Based on the earnings, the company is expensive. -2
  • The TTM is 35.887. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD-6.016MRQ-5.374-0.641
MRQ-5.374TTM35.887-41.261
TTM35.887YOY60.737-24.850
TTM35.8875Y12.752+23.135
5Y12.75210Y12.7520.000
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Knight Therapeutics Inc:

  • The EOD is 9.021. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 8.060. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -23.150. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD9.021MRQ8.060+0.962
MRQ8.060TTM-23.150+31.209
TTM-23.150YOY-18.939-4.211
TTM-23.1505Y3.207-26.357
5Y3.20710Y3.2070.000
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Knight Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 0.48 means the investor is paying €0.48 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Knight Therapeutics Inc:

  • The EOD is 0.534. Based on the equity, the company is cheap. +2
  • The MRQ is 0.477. Based on the equity, the company is cheap. +2
  • The TTM is 0.429. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.534MRQ0.477+0.057
MRQ0.477TTM0.429+0.047
TTM0.429YOY0.521-0.092
TTM0.4295Y0.526-0.096
5Y0.52610Y0.5260.000
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Knight Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.4240.006-7766%0.053-902%0.410-203%0.410-203%
Book Value Per Share--7.3827.540-2%7.304+1%7.243+2%7.243+2%
Current Ratio--3.2023.2060%2.632+22%3.481-8%3.481-8%
Debt To Asset Ratio--0.2100.206+2%0.182+15%0.190+11%0.190+11%
Debt To Equity Ratio--0.2660.260+2%0.224+19%0.249+7%0.249+7%
Dividend Per Share----0%-0%-0%-0%
Eps---0.164-0.020-88%-0.019-89%0.005-3223%0.005-3223%
Free Cash Flow Per Share--0.1090.043+156%0.022+408%-0.056+152%-0.056+152%
Free Cash Flow To Equity Per Share---0.131-0.105-20%-0.054-59%-0.149+13%-0.149+13%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--3.844--------
Intrinsic Value_10Y_min--3.103--------
Intrinsic Value_1Y_max---0.148--------
Intrinsic Value_1Y_min---0.146--------
Intrinsic Value_3Y_max---0.039--------
Intrinsic Value_3Y_min---0.046--------
Intrinsic Value_5Y_max--0.560--------
Intrinsic Value_5Y_min--0.485--------
Market Cap398609800.000+11%356119744.640341414018.240+4%435055007.545-18%450608428.816-21%450608428.816-21%
Net Profit Margin---0.328-0.059-82%-0.106-68%-0.027-92%-0.027-92%
Operating Margin---0.003-100%-0.0560%-0.0360%-0.0360%
Operating Ratio--1.5401.515+2%1.584-3%1.635-6%1.635-6%
Pb Ratio0.534+11%0.4770.429+11%0.521-8%0.526-9%0.526-9%
Pe Ratio-6.016-12%-5.37435.887-115%60.737-109%12.752-142%12.752-142%
Price Per Share3.940+11%3.5203.235+9%3.805-7%3.788-7%3.788-7%
Price To Free Cash Flow Ratio9.021+11%8.060-23.150+387%-18.939+335%3.207+151%3.207+151%
Price To Total Gains Ratio-9.294-12%-8.30319.211-143%-24.424+194%28.630-129%28.630-129%
Quick Ratio--1.7551.836-4%1.292+36%1.745+1%1.745+1%
Return On Assets---0.018-0.003-82%-0.005-72%0.000-100%0.000-100%
Return On Equity---0.022-0.004-82%-0.006-72%0.000-99%0.000-99%
Total Gains Per Share---0.4240.006-7766%0.053-902%0.410-203%0.410-203%
Usd Book Value--793251689.100846388552.100-6%886758176.525-11%906200359.567-12%906200359.567-12%
Usd Book Value Change Per Share---0.4500.006-7766%0.056-902%0.436-203%0.436-203%
Usd Book Value Per Share--7.8418.008-2%7.757+1%7.693+2%7.693+2%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.174-0.021-88%-0.020-89%0.006-3223%0.006-3223%
Usd Free Cash Flow--11732488.7124588552.394+156%2651762.329+342%-7080969.896+160%-7080969.896+160%
Usd Free Cash Flow Per Share--0.1160.045+156%0.023+408%-0.060+152%-0.060+152%
Usd Free Cash Flow To Equity Per Share---0.139-0.112-20%-0.057-59%-0.158+13%-0.158+13%
Usd Market Cap423363468.580+11%378234780.782362615828.773+4%462071923.514-18%478591212.245-21%478591212.245-21%
Usd Price Per Share4.185+11%3.7393.436+9%4.041-7%4.024-7%4.024-7%
Usd Profit---17594754.973-3044147.208-83%-5405146.917-69%55733.520-31669%55733.520-31669%
Usd Revenue--53665955.55059345771.882-10%53082802.907+1%44444569.334+21%44444569.334+21%
Usd Total Gains Per Share---0.4500.006-7766%0.056-902%0.436-203%0.436-203%
 EOD+4 -4MRQTTM+7 -26YOY+13 -195Y+13 -1910Y+13 -19

3.2. Fundamental Score

Let's check the fundamental score of Knight Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-6.016
Price to Book Ratio (EOD)Between0-10.534
Net Profit Margin (MRQ)Greater than0-0.328
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.755
Current Ratio (MRQ)Greater than13.202
Debt to Asset Ratio (MRQ)Less than10.210
Debt to Equity Ratio (MRQ)Less than10.266
Return on Equity (MRQ)Greater than0.15-0.022
Return on Assets (MRQ)Greater than0.05-0.018
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Knight Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose3.920
Total0/1 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Net Interest Income  1,342-960382-32657251308-995-687



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets945,493
Total Liabilities198,622
Total Stockholder Equity746,871
 As reported
Total Liabilities 198,622
Total Stockholder Equity+ 746,871
Total Assets = 945,493

Assets

Total Assets945,493
Total Current Assets365,115
Long-term Assets580,378
Total Current Assets
Cash And Cash Equivalents 58,761
Short-term Investments 111,410
Net Receivables 88,722
Inventory 91,834
Total Current Assets  (as reported)365,115
Total Current Assets  (calculated)350,727
+/- 14,388
Long-term Assets
Property Plant Equipment 17,859
Goodwill 79,844
Long Term Investments 120,023
Intangible Assets 289,960
Long-term Assets  (as reported)580,378
Long-term Assets  (calculated)507,686
+/- 72,692

Liabilities & Shareholders' Equity

Total Current Liabilities114,029
Long-term Liabilities84,593
Total Stockholder Equity746,871
Total Current Liabilities
Short Long Term Debt 17,850
Accounts payable 85,366
Other Current Liabilities 1,046
Total Current Liabilities  (as reported)114,029
Total Current Liabilities  (calculated)104,262
+/- 9,767
Long-term Liabilities
Long term Debt 44,016
Capital Lease Obligations Min Short Term Debt7,225
Long-term Liabilities  (as reported)84,593
Long-term Liabilities  (calculated)51,241
+/- 33,352
Total Stockholder Equity
Retained Earnings 150,888
Total Stockholder Equity (as reported)746,871
Total Stockholder Equity (calculated)150,888
+/- 595,983
Other
Capital Stock540,046
Common Stock Shares Outstanding 101,170
Net Debt 3,105
Net Invested Capital 808,737
Net Working Capital 251,086
Property Plant and Equipment Gross 39,462



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
1,022,261
1,305,303
1,267,135
1,224,748
1,013,963
1,039,676
1,000,795
1,043,647
1,037,614
991,891
995,422
1,001,134
1,035,343
1,054,836
1,044,774
1,013,743
1,011,149
945,493
945,4931,011,1491,013,7431,044,7741,054,8361,035,3431,001,134995,422991,8911,037,6141,043,6471,000,7951,039,6761,013,9631,224,7481,267,1351,305,3031,022,261
   > Total Current Assets 
599,518
698,224
737,556
721,182
540,619
552,101
552,517
330,030
343,070
304,969
331,011
320,351
342,848
395,619
403,210
385,367
401,296
365,115
365,115401,296385,367403,210395,619342,848320,351331,011304,969343,070330,030552,517552,101540,619721,182737,556698,224599,518
       Cash And Cash Equivalents 
319,125
169,268
262,623
340,275
218,091
229,592
271,218
102,582
92,490
85,963
113,457
93,119
101,822
71,679
56,218
37,844
77,418
58,761
58,76177,41837,84456,21871,679101,82293,119113,45785,96392,490102,582271,218229,592218,091340,275262,623169,268319,125
       Short-term Investments 
266,548
261,348
269,025
206,337
185,192
181,747
151,232
87,171
77,417
77,030
56,940
56,812
60,492
119,542
127,156
125,402
105,527
111,410
111,410105,527125,402127,156119,54260,49256,81256,94077,03077,41787,171151,232181,747185,192206,337269,025261,348266,548
       Net Receivables 
4,726
125,171
118,774
89,000
82,101
93,278
81,743
90,865
105,520
69,962
83,855
94,606
99,089
115,635
103,573
126,957
103,337
88,722
88,722103,337126,957103,573115,63599,08994,60683,85569,962105,52090,86581,74393,27882,10189,000118,774125,1714,726
       Inventory 
472
70,870
72,125
71,836
61,783
56,505
55,044
55,784
74,912
72,397
76,652
76,400
84,942
92,489
98,988
98,682
112,447
91,834
91,834112,44798,68298,98892,48984,94276,40076,65272,39774,91255,78455,04456,50561,78371,83672,12570,870472
       Other Current Assets 
197
84,578
28,396
22,059
2,664
179
2,613
180
180
289
273
261
401
181
0
7,900
40,487
0
040,4877,90001814012612732891801802,6131792,66422,05928,39684,578197
   > Long-term Assets 
422,743
683,779
532,119
506,127
475,828
487,575
450,711
713,617
694,544
686,922
664,411
678,961
690,709
659,217
641,564
626,949
609,853
580,378
580,378609,853626,949641,564659,217690,709678,961664,411686,922694,544713,617450,711487,575475,828506,127532,119683,779422,743
       Property Plant Equipment 
1,679
29,048
29,120
27,769
26,630
26,162
26,099
27,314
28,003
29,936
31,280
32,431
35,574
22,633
22,265
20,079
20,455
17,859
17,85920,45520,07922,26522,63335,57432,43131,28029,93628,00327,31426,09926,16226,63027,76929,12029,0481,679
       Goodwill 
0
88,262
84,341
80,443
77,770
77,725
74,091
76,273
75,999
75,403
80,749
79,818
83,412
82,274
84,797
85,738
85,883
79,844
79,84485,88385,73884,79782,27483,41279,81880,74975,40375,99976,27374,09177,72577,77080,44384,34188,2620
       Long Term Investments 
359,229
259,717
197,690
175,787
162,185
174,841
153,853
193,732
175,865
178,952
155,391
148,610
149,739
158,016
141,903
139,258
129,340
120,023
120,023129,340139,258141,903158,016149,739148,610155,391178,952175,865193,732153,853174,841162,185175,787197,690259,717359,229
       Intangible Assets 
0
173,372
164,439
164,950
156,641
156,547
146,227
363,359
359,432
350,299
343,480
365,115
370,888
338,780
331,518
318,638
311,201
289,960
289,960311,201318,638331,518338,780370,888365,115343,480350,299359,432363,359146,227156,547156,641164,950164,439173,3720
       Other Assets 
69,982
75,268
74,282
79,673
73,950
75,487
71,428
76,757
79,094
57,053
59,203
59,288
57,420
63,201
0
73,826
180,957
0
0180,95773,826063,20157,42059,28859,20357,05379,09476,75771,42875,48773,95079,67374,28275,26869,982
> Total Liabilities 
64,082
390,197
390,774
345,750
131,741
153,435
171,320
154,207
165,017
149,873
165,843
171,445
180,827
228,979
225,905
206,544
196,484
198,622
198,622196,484206,544225,905228,979180,827171,445165,843149,873165,017154,207171,320153,435131,741345,750390,774390,19764,082
   > Total Current Liabilities 
58,270
350,804
356,470
311,996
99,031
114,060
135,945
117,773
132,553
105,302
121,317
126,034
139,532
141,321
135,452
121,995
115,077
114,029
114,029115,077121,995135,452141,321139,532126,034121,317105,302132,553117,773135,945114,06099,031311,996356,470350,80458,270
       Short Long Term Debt 
0
50,557
54,207
44,074
41,567
51,770
38,192
35,149
36,328
26,662
31,140
24,335
25,148
17,674
20,293
21,097
25,684
17,850
17,85025,68421,09720,29317,67425,14824,33531,14026,66236,32835,14938,19251,77041,56744,07454,20750,5570
       Accounts payable 
9,298
72,831
79,770
66,518
42,475
44,512
45,385
66,127
76,792
65,309
77,944
82,402
90,865
106,061
107,989
93,537
82,782
85,366
85,36682,78293,537107,989106,06190,86582,40277,94465,30976,79266,12745,38544,51242,47566,51879,77072,8319,298
       Other Current Liabilities 
35,987
204,053
220,747
199,896
13,900
15,903
50,838
14,656
17,961
11,717
10,556
17,279
21,226
5,793
1,687
5,419
4,771
1,046
1,0464,7715,4191,6875,79321,22617,27910,55611,71717,96114,65650,83815,90313,900199,896220,747204,05335,987
   > Long-term Liabilities 
5,812
39,393
34,304
33,754
32,710
39,375
35,375
36,434
32,464
44,571
44,526
45,411
41,295
87,658
90,453
84,549
81,407
84,593
84,59381,40784,54990,45387,65841,29545,41144,52644,57132,46436,43435,37539,37532,71033,75434,30439,3935,812
       Capital Lease Obligations Min Short Term Debt
1,001
6,600
6,193
5,274
4,440
4,418
3,704
4,735
4,190
5,031
5,763
5,731
5,843
7,628
7,304
6,739
6,653
7,225
7,2256,6536,7397,3047,6285,8435,7315,7635,0314,1904,7353,7044,4184,4405,2746,1936,6001,001
       Other Liabilities 
5,109
29,559
25,611
28,048
27,519
36,832
33,201
33,540
29,746
31,889
30,555
33,550
29,673
0
0
28,388
26,914
0
026,91428,3880029,67333,55030,55531,88929,74633,54033,20136,83227,51928,04825,61129,5595,109
> Total Stockholder Equity
958,179
810,731
783,561
791,866
882,222
886,241
829,475
889,440
872,597
842,018
829,579
829,689
854,516
825,857
818,869
807,199
814,665
746,871
746,871814,665807,199818,869825,857854,516829,689829,579842,018872,597889,440829,475886,241882,222791,866783,561810,731958,179
   Common Stock
698,115
723,832
698,249
699,067
695,066
694,351
641,461
668,425
652,681
628,854
619,675
611,967
607,765
0
0
571,928
560,500
0
0560,500571,92800607,765611,967619,675628,854652,681668,425641,461694,351695,066699,067698,249723,832698,115
   Retained Earnings 
227,405
52,246
40,760
58,209
166,306
174,545
181,207
207,645
199,531
191,647
172,920
175,503
176,909
161,755
158,978
162,449
173,735
150,888
150,888173,735162,449158,978161,755176,909175,503172,920191,647199,531207,645181,207174,545166,30658,20940,76052,246227,405
   Capital Surplus 000000000000000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 
16,694
18,190
27,619
17,708
2,647
-1,386
-12,435
-7,712
-1,085
-259
14,823
19,283
46,646
0
0
47,547
54,806
0
054,80647,5470046,64619,28314,823-259-1,085-7,712-12,435-1,3862,64717,70827,61918,19016,694



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue328,199
Cost of Revenue-175,547
Gross Profit152,652152,652
 
Operating Income (+$)
Gross Profit152,652
Operating Expense-321,829
Operating Income6,370-169,177
 
Operating Expense (+$)
Research Development17,549
Selling General Administrative83,693
Selling And Marketing Expenses-
Operating Expense321,829101,242
 
Net Interest Income (+$)
Interest Income12,575
Interest Expense-12,488
Other Finance Cost-0
Net Interest Income87
 
Pretax Income (+$)
Operating Income6,370
Net Interest Income87
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-21,98834,815
EBIT - interestExpense = -12,488
-16,835
-4,347
Interest Expense12,488
Earnings Before Interest and Taxes (EBIT)--9,500
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-21,988
Tax Provision--5,153
Net Income From Continuing Ops-16,835-16,835
Net Income-16,835
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-28,445-87
 

Technical Analysis of Knight Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Knight Therapeutics Inc. The general trend of Knight Therapeutics Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Knight Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Knight Therapeutics Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 4.1 < 4.12 < 4.2.

The bearish price targets are: 3.9 > 3.88 > 3.88.

Tweet this
Knight Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Knight Therapeutics Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Knight Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Knight Therapeutics Inc.

Knight Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartKnight Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Knight Therapeutics Inc. The current adx is .

Knight Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Knight Therapeutics Inc.

Knight Therapeutics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Knight Therapeutics Inc.

Knight Therapeutics Inc Daily Relative Strength Index (RSI) ChartKnight Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Knight Therapeutics Inc.

Knight Therapeutics Inc Daily Stochastic Oscillator ChartKnight Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Knight Therapeutics Inc.

Knight Therapeutics Inc Daily Commodity Channel Index (CCI) ChartKnight Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Knight Therapeutics Inc.

Knight Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartKnight Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Knight Therapeutics Inc.

Knight Therapeutics Inc Daily Williams %R ChartKnight Therapeutics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Knight Therapeutics Inc.

Knight Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Knight Therapeutics Inc.

Knight Therapeutics Inc Daily Average True Range (ATR) ChartKnight Therapeutics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Knight Therapeutics Inc.

Knight Therapeutics Inc Daily On-Balance Volume (OBV) ChartKnight Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Knight Therapeutics Inc.

Knight Therapeutics Inc Daily Money Flow Index (MFI) ChartKnight Therapeutics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Knight Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-01 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-04 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-06 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-08 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-12 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-14 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-20 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-22 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-27 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-29 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-05 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-19 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-25 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-26 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-09 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-12 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-13 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-16 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-19 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-23 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-28 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-29 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-01 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-04 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-06 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-13 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-18 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-19 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-26 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-02 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-04 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-05 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-09 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-11 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Knight Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Knight Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose3.920
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Knight Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Knight Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Knight Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Knight Therapeutics Inc

I send you an email if I find something interesting about Knight Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Knight Therapeutics Inc.

Receive notifications about Knight Therapeutics Inc in your mailbox!